Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 119005
Published online Jun 27, 2026. doi: 10.4254/wjh.119005
Published online Jun 27, 2026. doi: 10.4254/wjh.119005
Table 2 Observed prevalence of significant fibrosis across model-defined risk strata within the fibrosis-4 indeterminate zone (n = 129)
| Group | n | S ≥ 21 | S ≥ 2 (%) |
| Low risk | 54 | 7 | 13.0 |
| Uncertain | 39 | 14 | 35.9 |
| High risk | 36 | 27 | 75.0 |
- Citation: Wang TT, Chu YL, Lou YQ, Yang RY, Pu MM, Shan LJ, Huang L, Chen SS, Huang HJ. Routine laboratory model for identifying significant fibrosis in chronic hepatitis B. World J Hepatol 2026; 18(6): 119005
- URL: https://www.wjgnet.com/1948-5182/full/v18/i6/119005.htm
- DOI: https://dx.doi.org/10.4254/wjh.119005